Recombinant proteins market size to grow by USD 650.96 million from 2022 to 2027, 35% of market growth to originate from North America - Technavio

NEW YORK, May 31, 2023 /PRNewswire/ -- The recombinant proteins market size is expected to grow by USD 650.96 million from 2022 to 2027 at a CAGR of 9.46%, as per the latest Technavio market research report. North America is expected to account for 35% of the market's growth during the forecast period. This growth is attributed to factors such as the high uptake of recombinant proteins. The increasing prevalence of cancer, autoimmune diseases, metabolic diseases, musculoskeletal diseases, central nervous system diseases, and hematological diseases are also contributing to market growth. In addition, Factors such as rising R&D spending, increasing research activity, favorable government funding, and the presence of key players are boosting the market expansion in the region during the forecast period. For more insights on the market share of various regions - Download sample report in MINUTES

Recombinant proteins market: Increase in chronic diseases to drive growth

Chronic diseases such as cancer, cardiovascular, endocrine, and viral diseases can be treated with recombinant proteins. Therefore, the rising prevalence of such diseases is expected to boost the demand for recombinant proteins during the forecast period. For instance, according to the World Health Organization, cancer is the second leading cause of death worldwide. The prevalence of cardiovascular diseases and cancer is increasing worldwide. Similarly, the rising prevalence of other chronic diseases, such as cardiovascular diseases and neurological disorders, will increase the demand for recombinant proteins during the forecast period.

Recombinant Proteins Market: Growing opportunities from emerging economies 

Emerging economies in Asia offer high growth potential for market participants. Factors such as aging population, rising income levels, improved healthcare infrastructure, increasing healthcare costs, and low-cost manufacturing are encouraging market participants to invest in the region. The regulatory framework in Asia is more flexible and business-friendly and attracts larger companies that are facing stiff competition in established markets. Governments of emerging countries in Asia are taking steps to raise awareness about cancer to enable early diagnosis. Such policies are expected to boost the growth of the market during the forecast period.

To know about more drivers, trends, and challenges - Download a sample now!

Some of the key recombinant proteins market players:

The recombinant proteins market is fragmented , and the vendors are deploying organic and inorganic growth strategies to compete in the market. Some of the key players in the market are listed below:

• Abcam plc
• Airway Therapeutics Inc.
• Amgen Inc.
• Aviva Systems Biology Corp.
• Bio Techne Corp.
• Bio Rad Laboratories Inc.
• BPS Bioscience Inc.
• Elabscience Biotechnology Inc.
• Enzo Biochem Inc.
• GenScript Biotech Corp.
• Grifols SA
• Merck KGaA
• Novartis AG
• Novo Nordisk AS
• OriGene Technologies Inc.
• Prospec Tany Technogene Ltd.
• Proteintech Group Inc.
• Sanofi SA
• Sino Biological Inc.
• Thermo Fisher Scientific Inc.

Gain instant access to our 17,000+ market research reports

Technavio's SUBSCRIPTION platform

Recombinant proteins market: Segmentation analysis

This market research report segments the recombinant proteins market by application (biotechnology research, drug discovery and development, biopharmaceutical production, and others), end-user (pharma and biotechnology companies, academic and research institutes, and others), and geography (North America, Europe, Asia, and Rest of World (ROW)).

The biotechnology research segment will account for a significant share of market growth during the forecast period. Recombinant proteins have contributed to major advances in biomedical biotechnology. These include proteins generated in course-specific research projects as well as commercially available proteins. Recombinant proteins are also used in food production, agriculture, and biotechnology. In addition, researchers have used genetic techniques to modify proteins to create recombinant therapeutic proteins. Such factors will drive the growth of the segment during the forecast period.

For additional information on the market contribution of each segment - Grab an exclusive sample report

Some of the key topics covered in the report include:

Market drivers

Market challenges

Market trends

Vendor landscape

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Competitive scenario

Related reports:

The protein supplements market is estimated to grow at a CAGR of 8.18% between 2022 and 2027. The market size is forecast to increase by USD 10.9 billion. This report extensively covers market segmentation by source (animal-based and plant-based), distribution channel (retail outlets and online stores), and geography (North America, Europe, Asia, and Rest of World (ROW)).

The protein therapeutics market is estimated to grow at a CAGR of 9.14% between 2022 and 2027. The market size is forecasted to increase by USD 153.56 billion. This report extensively covers market segmentation by product (mABs, human insulin, erythropoietin, clotting factors, and others), application (metabolic disorders, immunologic disorders, hematological disorders, cancer, and genetic disorders), and geography (North America, Europe, Asia, and Rest of World (ROW)).

Browse for Technavio Health care market reports

Table of contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global recombinant proteins market 2017 - 2021 
• Exhibit 18: Historic Market Size – Data Table on global recombinant proteins market 2017 - 2021 ($ million)

• 4.2 Application Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ million)

• 4.3 End-user Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

• 6.1 Market segments
• Exhibit 30: Chart on Application - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Application - Market share 2022-2027 (%)

• 6.2 Comparison by Application 
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application

• 6.3 Biotechnology research - Market size and forecast 2022-2027 
• Exhibit 34: Chart on Biotechnology research - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Biotechnology research - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Biotechnology research - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Biotechnology research - Year-over-year growth 2022-2027 (%)

• 6.4 Drug discovery and development - Market size and forecast 2022-2027 
• Exhibit 38: Chart on Drug discovery and development - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Drug discovery and development - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Drug discovery and development - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Drug discovery and development - Year-over-year growth 2022-2027 (%)

• 6.5 Biopharmaceutical production - Market size and forecast 2022-2027 
• Exhibit 42: Chart on Biopharmaceutical production - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Biopharmaceutical production - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Biopharmaceutical production - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Biopharmaceutical production - Year-over-year growth 2022-2027 (%)

• 6.6 Others - Market size and forecast 2022-2027 
• Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)

• 6.7 Market opportunity by Application 
• Exhibit 50: Market opportunity by Application ($ million)
• Exhibit 51: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 52: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 53: Data Table on End-user - Market share 2022-2027 (%)

• 7.2 Comparison by End-user 
• Exhibit 54: Chart on Comparison by End-user
• Exhibit 55: Data Table on Comparison by End-user

• 7.3 Pharma and biotechnology companies - Market size and forecast 2022-2027 
• Exhibit 56: Chart on Pharma and biotechnology companies - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Pharma and biotechnology companies - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Pharma and biotechnology companies - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Pharma and biotechnology companies - Year-over-year growth 2022-2027 (%)

• 7.4 Academic and research institutes - Market size and forecast 2022-2027 
• Exhibit 60: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)

• 7.5 Others - Market size and forecast 2022-2027 
• Exhibit 64: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 67: Data Table on Others - Year-over-year growth 2022-2027 (%)

• 7.6 Market opportunity by End-user 
• Exhibit 68: Market opportunity by End-user ($ million)
• Exhibit 69: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 71: Chart on Market share by geography 2022-2027 (%)
• Exhibit 72: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 73: Chart on Geographic comparison
• Exhibit 74: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027 
• Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027 
• Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027 
• Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027 
• Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 China - Market size and forecast 2022-2027 
• Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.9 Germany - Market size and forecast 2022-2027 
• Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.10 Italy - Market size and forecast 2022-2027 
• Exhibit 103: Chart on Italy - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on Italy - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on Italy - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on Italy - Year-over-year growth 2022-2027 (%)

• 9.11 Japan - Market size and forecast 2022-2027 
• Exhibit 107: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 108: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 109: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 110: Data Table on Japan - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 111: Market opportunity by geography ($ million)
• Exhibit 112: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 113: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
• Exhibit 114: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
• Exhibit 115: Overview on factors of disruption

• 11.4 Industry risks
• Exhibit 116: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 117: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 118: Matrix on vendor position and classification

• 12.3 Abcam plc
• Exhibit 119: Abcam plc - Overview
• Exhibit 120: Abcam plc - Product / Service
• Exhibit 121: Abcam plc - Key news
• Exhibit 122: Abcam plc - Key offerings

• 12.4 Amgen Inc.
• Exhibit 123: Amgen Inc. - Overview
• Exhibit 124: Amgen Inc. - Product / Service
• Exhibit 125: Amgen Inc. - Key offerings

• 12.5 Aviva Systems Biology Corp. 
• Exhibit 126: Aviva Systems Biology Corp. - Overview
• Exhibit 127: Aviva Systems Biology Corp. - Product / Service
• Exhibit 128: Aviva Systems Biology Corp. - Key offerings

• 12.6 Bio Rad Laboratories Inc. 
• Exhibit 129: Bio Rad Laboratories Inc. - Overview
• Exhibit 130: Bio Rad Laboratories Inc. - Business segments
• Exhibit 131: Bio Rad Laboratories Inc. - Key news
• Exhibit 132: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 133: Bio Rad Laboratories Inc. - Segment focus

• 12.7 BPS Bioscience Inc.
• Exhibit 134: BPS Bioscience Inc. - Overview
• Exhibit 135: BPS Bioscience Inc. - Product / Service
• Exhibit 136: BPS Bioscience Inc. - Key offerings

• 12.8 Enzo Biochem Inc.
• Exhibit 137: Enzo Biochem Inc. - Overview
• Exhibit 138: Enzo Biochem Inc. - Product / Service
• Exhibit 139: Enzo Biochem Inc. - Key offerings

• 12.9 GenScript Biotech Corp. 
• Exhibit 140: GenScript Biotech Corp. - Overview
• Exhibit 141: GenScript Biotech Corp. - Business segments
• Exhibit 142: GenScript Biotech Corp. - Key news
• Exhibit 143: GenScript Biotech Corp. - Key offerings
• Exhibit 144: GenScript Biotech Corp. - Segment focus

• 12.10 Merck KGaA
• Exhibit 145: Merck KGaA - Overview
• Exhibit 146: Merck KGaA - Business segments
• Exhibit 147: Merck KGaA - Key news
• Exhibit 148: Merck KGaA - Key offerings
• Exhibit 149: Merck KGaA - Segment focus

• 12.11 Novartis AG
• Exhibit 150: Novartis AG - Overview
• Exhibit 151: Novartis AG - Business segments
• Exhibit 152: Novartis AG - Key offerings
• Exhibit 153: Novartis AG - Segment focus

• 12.12 Novo Nordisk AS
• Exhibit 154: Novo Nordisk AS - Overview
• Exhibit 155: Novo Nordisk AS - Business segments
• Exhibit 156: Novo Nordisk AS - Key offerings
• Exhibit 157: Novo Nordisk AS - Segment focus

• 12.13 Prospec Tany Technogene Ltd. 
• Exhibit 158: Prospec Tany Technogene Ltd. - Overview
• Exhibit 159: Prospec Tany Technogene Ltd. - Product / Service
• Exhibit 160: Prospec Tany Technogene Ltd. - Key offerings

• 12.14 Proteintech Group Inc. 
• Exhibit 161: Proteintech Group Inc. - Overview
• Exhibit 162: Proteintech Group Inc. - Product / Service
• Exhibit 163: Proteintech Group Inc. - Key offerings

• 12.15 Sanofi SA
• Exhibit 164: Sanofi SA - Overview
• Exhibit 165: Sanofi SA - Business segments
• Exhibit 166: Sanofi SA - Key news
• Exhibit 167: Sanofi SA - Key offerings
• Exhibit 168: Sanofi SA - Segment focus

• 12.16 Sino Biological Inc.
• Exhibit 169: Sino Biological Inc. - Overview
• Exhibit 170: Sino Biological Inc. - Product / Service
• Exhibit 171: Sino Biological Inc. - Key offerings

• 12.17 Thermo Fisher Scientific Inc. 
• Exhibit 172: Thermo Fisher Scientific Inc. - Overview
• Exhibit 173: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 174: Thermo Fisher Scientific Inc. - Key news
• Exhibit 175: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 176: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 177: Inclusions checklist
• Exhibit 178: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 179: Currency conversion rates for US$

• 13.4 Research methodology
• Exhibit 180: Research methodology
• Exhibit 181: Validation techniques employed for market sizing
• Exhibit 182: Information sources

• 13.5 List of abbreviations 
• Exhibit 183: List of abbreviations

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio